Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Use of Rv0222-Rv2657c-Rv1509 fusion protein to improve the accuracy of an antibody ELISA for extra-pulmonary tuberculosis in humans

Chen, Y., Ge, P., Zhang, K., Xiang, J., Zhang, L., Robertson, I.D.ORCID: 0000-0002-4255-4752 and Guo, A. (2021) Use of Rv0222-Rv2657c-Rv1509 fusion protein to improve the accuracy of an antibody ELISA for extra-pulmonary tuberculosis in humans. Pathogens, 10 (7). Article 828.

[img]
Preview
PDF - Published Version
Download (772kB) | Preview
Free to read: https://doi.org/10.3390/pathogens10070828
*No subscription required

Abstract

(1) Background: Tuberculosis (TB) in humans is a serious chronic epidemic disease caused by Mycobacterium tuberculosis (M. tb). The diagnosis of TB, especially extra-pulmonary TB (EPTB), is difficult. Isolation of M. tb from culture has a low sensitivity in patients with TB and an even lower sensitivity in cases of EPTB. Although Xpert MTB/RIF assays and serological tests are more sensitive than the above tests, they still lack sensitivity for EPTB diagnosis. (2) Methods: To improve the accuracy of TB diagnosis, a Rv0222-Rv2657c-Rv1509 fusion protein based iELISA was constructed, the diagnosis of TB, pulmonary TB (PTB) and EPTB was then evaluated. Sera of 40 TB patients including 14 with PTB, 14 with EPTB and 12 with no information about the form of TB, and five pneumonia patients were investigated. (3) Results: The sensitivity of the ELISA in TB, PTB and EPTB patients was 80% (95% CI: 64.4, 90.9%), 85.7% (95% CI: 57.2, 98.2%) and 92.8% (95% CI: 66.1, 99.8%), respectively, with a specificity of 70% (95% CI: 53.5, 83.4%). Both the sensitivity and specificity with this fusion protein were higher than for CFP10/ESAT6 (used as reference antigen) fusion protein (71.4%; 95% CI: 41.9, 91.6%, and 67.5%; 95% CI: 50.9, 81.4%), respectively, in cases of EPTB. All pneumonia patients’ sera tested negative in both ELISAs. (4) Conclusion: use of these new fusion proteins as antigens in serological assays has the potential to improve the diagnosis of all forms of TB in humans, especially EPTB.

Item Type: Journal Article
Murdoch Affiliation(s): Veterinary Medicine
Publisher: MDPI
Copyright: © 2021 by the authors
URI: http://researchrepository.murdoch.edu.au/id/eprint/61698
Item Control Page Item Control Page

Downloads

Downloads per month over past year